CDMO Onyx Scientific has opened a second facility at its headquarters site in Sunderland, UK.This doubles its footprint and allows for expansion of all CMC activities, including additional GMP facilities that increases capacity for GMP and commercial API manufacturing capacity by 50%.
Nouryon plans to expand its capacity for monochloroacetic acid (MCA) at Delfzijl, Netherlands, by the end of 2020. Together with the opening of a new joint venture plant in India later this year, which will increase its global capacity by 20%.
Nouryon has completed two recently announced advances: the acquisition of the carboxymethyl cellulose (CMC) business of J.M. Huber, including a manufacturing plant and advanced R&D facility located in Äänekoski, Finland; and doubling organic peroxides at its plant in Itupeva, Brazil.